Paul Tudor Jones Castle Biosciences Inc Transaction History
Tudor Investment Corp Et Al
- $15.5 Billion
- Q1 2024
A detailed history of Paul Tudor Jones (Tudor Investment Corp Et Al) transactions in Castle Biosciences Inc stock. As of the latest transaction made, Tudor Investment Corp Et Al holds 12,997 shares of CSTL stock, worth $282,944. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,997Holding current value
$282,944% of portfolio
0.0%Shares
5 transactions
Others Institutions Holding CSTL
# of Institutions
162Shares Held
25.3MCall Options Held
82.2KPut Options Held
150K-
Black Rock Inc. New York, NY2.6MShares$56.5 Million0.0% of portfolio
-
Wasatch Advisors Inc Salt Lake City, UT2.55MShares$55.5 Million0.3% of portfolio
-
Granahan Investment Management, LLC Waltham, MA1.63MShares$35.4 Million1.3% of portfolio
-
Principal Financial Group Inc Des Moines, IA1.53MShares$33.4 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.49MShares$32.5 Million0.0% of portfolio
About CASTLE BIOSCIENCES INC
- Ticker CSTL
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 26,297,000
- Market Cap $572M
- Description
- Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company als...